• >
  • Publications
  • >
  • Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy

Cite this Publication

APA 7th Edition

D’Argenio V, Salvatore F. (2020). Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy. Home of Research Journal.

MLA 9th Edition

D’Argenio V, Salvatore F. “Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy.” Home of Research, 2020.

Harvard

D’Argenio V, Salvatore F. (2020) Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy, Home of Research.

Chicago Style

D’Argenio V, Salvatore F. “Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy.” Home of Research. 2020.